Male birth control pill clears initial safety hurdle

YourChoice Therapeutics, working with Quotient Sciences and Incyte, reports that single oral doses of the investigational non‑hormonal male contraceptive YCT‑529 up to 180 mg produced no clinically relevant safety issues in 16 healthy men.

Mamdani Is In BIG TROUBLE
- Wendy's tops list as unhealthiest fast-food chain, says report
- New Report Blows Lid Off of Democrat Doomcasting on Federal Defunding of NPR and PBS
- Keanu Reeves Overlooked Sexy Horror Film Is Finally Streaming - Chris Snellgrove
- Ten U.S. Hostages Freed From Venezuelan Prison. El Salvador’s President Bukele Steps Up to Help Bring Them Home. - Diana Zapata
- Can cannabis impact aging? Study shows marijuana could alter 'genetic code'
- Pollster Matt Towery Explains Why Trump’s Actual Approval Numbers Far Exceed Media Claims - Mariane Angela

The "Unpredictable Future" Fallacy: Is Retirement Planning Worthless?
- The Full Moons of 2024: A Comprehensive Guide to Their Names and Dates - Arya Chandran
- This Overlooked Leafy Green Is In Season Right Now—and Packed With Nutrients - Christina Manian, RDN
- AI Voices in Gaming: A Glitch or The Future? Prince of Persia: The Lost Crown's Case - Michael A. Medeiros
- How To Become A Grant Writer With No Experience - Aamir Zahoor
- Qwen3-Coder-480B-A35B-Instruct launches and it ‘might be the best coding model yet’ - Carl Franzen
- Russia Advances Rapidly in Eastern Ukraine: Over a Dozen Settlements Captured in One Week - MeighTimbol